| Holding(s) in Company | 17-Nov-2025 | 11:37 | RNS |
| Holding(s) in Company | 11-Nov-2025 | 09:50 | RNS |
| Enhanced IP Coverage: AT278 & Oral Peptide Program | 04-Nov-2025 | 07:00 | RNS |
| Directorate Changes | 29-Sep-2025 | 07:00 | RNS |
| Interim results for the six months to 30 June 2025 | 25-Sep-2025 | 07:00 | RNS |
| Co-Development Agreement & Monetisation Deal | 25-Sep-2025 | 07:00 | RNS |
| Notice of Interim Results | 24-Sep-2025 | 09:30 | RNS |
| Positive FDA Feedback on Phase 2 Study Design | 04-Sep-2025 | 07:00 | RNS |
| Holding(s) in Company | 28-Aug-2025 | 12:00 | RNS |
| Change of Auditor | 08-Aug-2025 | 07:00 | RNS |
| Grant of Options and PDMR Dealing | 04-Jun-2025 | 07:00 | RNS |
| Result of AGM | 02-Jun-2025 | 13:32 | RNS |
| Non-Executive Director Board Change | 02-Jun-2025 | 07:00 | RNS |
| Director/PDMR Dealing | 21-May-2025 | 07:00 | RNS |
| Arecor Partnership with Skye Bioscience | 19-May-2025 | 07:00 | RNS |
| Currency | UK Pounds |
| Share Price | 74.00p |
| Change Today | 1.50p |
| % Change | 2.07 % |
| 52 Week High | 86.50p |
| 52 Week Low | 38.00p |
| Volume | 16,988 |
| Shares Issued | 37.76m |
| Market Cap | £27.94m |
| Beta | 0.38 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| No dividends found |
| Time | Volume / Share Price |
| 14:16 | 1,824 @ 76.44p |
| 12:07 | 10,000 @ 75.50p |
| 11:44 | 130 @ 76.44p |
| 10:43 | 3,891 @ 74.40p |
| 08:32 | 3 @ 70.00p |
You are here: research